Postgraduate Studentships - Search for funding opportunities.
Postgraduate Studentships - Search for funding opportunities.
Study Details: MSc: 1 year full-time, 2 years part-time
London Met’s Cancer Pharmacology master’s course explores the nature of cancer at the systems, cellular and molecular levels, and focuses on the drugs which are used to treat different cancers and how they work. By the end of the MSc, you will have developed a deep understanding of how chemotherapeutic agents are used to target and kill cancer cells as part of a central strategy in the treatment of cancers.
In the most recent Destinations of Leavers from Higher Education (DLHE) survey, 100% of all 2017 graduates from this course were in work or further study within six months.
At least a lower second class (2.2) UK first degree (or equivalent) in an appropriate subject, for example pharmacology, biomedical science, biological science or medical genetics (these will be considered on an individual basis).
For fee details please see here
Our graduates primarily go on to pursue a career in anti-cancer drug development in academia or the pharmaceutical industry. The programme also provides an excellent basis for further research or study.
Year 1 modules include:
Cancer Pharmacology (core, 20 credits)
Cancer: Diagnosis and Therapy (core, 20 credits)
Medical Genetics and Genomics (core, 20 credits)
Molecular Oncology (core, 20 credits)
Research Project (core, 60 credits)
Scientific Frameworks For Research (core, 20 credits)
Advanced Drug Formulation Technologies (option, 20 credits)
Bioinformatics and Molecular Modelling (option, 20 credits)
Drug Discovery Technology (option, 20 credits)
Whether you’re looking to improve your job prospects, pursue a passion or take your career in a whole new direction, London Met has the right postgrad...
